Search

everythinglearnresearchcommunity

for

Search:↓

PTEN was identified as a specific marker for the skin disease cutaneous lupus erythematosus, and it helps increase the expression of harmful type I interferons.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Wnt-10b helps skin cells and hair grow.

Interleukin 6 may help protect skin without causing inflammation.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Myeloid-derived suppressor cells help control autoimmune cells and promote hair regrowth in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Sirolimus and propranolol may reduce abnormal cell growth and improve lymphatic malformations in children.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The document concludes that understanding how the skin's immune system and inflammation work is complex and requires more research to improve treatments for skin diseases.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

The paper concludes that understanding melanocyte development can help in insights into skin diseases and melanoma diversity.

Stress can worsen skin and hair conditions by affecting the skin's immune response and hormone levels.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

The document concludes that the understanding of scar formation is incomplete and current prevention and treatment for hypertrophic scars and keloids are not fully effective.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.